Skip to content
  • Products & Services
    • SEQ
    • Covid19-qPCR
    • Pathogenicity Calculator
  • Our Company
    • About Us
    • Careers
    • News & Events
    • Contact Us
    • Certifications & Compliances
  • Science Hub
    • Blog
    • White Papers
    • Citations
  • Products & Services
    • SEQ
    • Covid19-qPCR
    • Pathogenicity Calculator
  • Our Company
    • About Us
    • Careers
    • News & Events
    • Contact Us
    • Certifications & Compliances
  • Science Hub
    • Blog
    • White Papers
    • Citations
Sign In to SEQ
Schedule A Demo

Genomize in Scientific Articles

You are here:
  1. Home
  2. Citations
Orange document icon with pencil
IKZF1 Deletions at Diagnose and Relapse of Childhood B-ALL
American Society of Hematology - Blood, 2017

Erbilgin et al. (2026) used Genomize-SEQ to confirm IKZF1 deletions were nearly twice as common in relapsed pediatric B-ALL patients as at diagnosis, suggesting these deletions accumulate during disease progression rather than predicting relapse from the outset.

Orange document icon with pencil
A novel pathogenic frameshift variant of CD3E gene in two T-B+ NK+ SCID patients from Turkey
Immunogenetics, 2017

Using targeted NGS and Genomize-SEQ variant analysis, Firtina et al. (2017) found an identical novel CD3E frameshift deletion in two unrelated consanguineous Turkish families with T-B+ NK+ SCID. This finding suggests a possible founder effect and expands the known mutational spectrum of CD3E-deficiency.

←123456

Become a part of Genomize community!

Genomize_logo
info@genomize.com
Linkedin Facebook Twitter Instagram

Products & Services

  • SEQ Platform
  • Covid19-qPCR
  • Pathogenicity Calculator

Our Company

  • About Us
  • Careers
  • Contact Us
  • Certifications & Compliances

Science Hub

  • Blog
  • White Papers
  • Citations
© 2026 Genomize. All rights reserved.
Go to Top